ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. Post author:admERY Post published:June 17, 2012 Post category:Newsroom You Might Also Like ERYTECH gives feedback on its first Investor R&D Day and provides a financial and business update for Q4 2013 January 27, 2014 ERYTECH Announces Management Change January 4, 2016 ERYTECH Presents New Preclinical Data on ERY-MET at the 2017 ASCO GI Symposium January 17, 2017
ERYTECH gives feedback on its first Investor R&D Day and provides a financial and business update for Q4 2013 January 27, 2014
